🇺🇸 FDA
Pipeline program

Radiation: 131I-MIBG

NANT 2021-02

Phase 2 small_molecule active

Quick answer

Radiation: 131I-MIBG for Neuroblastoma is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Neuroblastoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials